Weighted Average Number of Shares Outstanding, Basic of ArriVent BioPharma, Inc. from 31 Mar 2023 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
ArriVent BioPharma, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Mar 2023 to 31 Dec 2025.
  • ArriVent BioPharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 38,462,600, a 22% increase year-over-year.
  • ArriVent BioPharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 38,462,600, a 22% increase from 2024.
  • ArriVent BioPharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 31,469,328, a 1370% increase from 2023.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

ArriVent BioPharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 38,462,600 +6,993,272 +22% 01 Oct 2025 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q3 2025 41,912,905 +8,331,095 +25% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 35,006,114 +1,503,767 +4.5% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 33,898,870 +8,852,339 +35% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 31,469,328 +29,328,377 +1370% 01 Oct 2024 31 Dec 2024 10-K 05 Mar 2026 2025 FY
Q3 2024 33,581,810 +30,974,618 +1188% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2025 Q3
Q2 2024 33,502,347 +31,502,642 +1575% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 25,046,531 +23,758,957 +1845% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 2,140,951 01 Oct 2023 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 2,607,192 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 1,999,705 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 1,287,574 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1

ArriVent BioPharma, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 38,462,600 +6,993,272 +22% 01 Jan 2025 31 Dec 2025 10-K 05 Mar 2026 2025 FY
2024 31,469,328 +29,328,377 +1370% 01 Jan 2024 31 Dec 2024 10-K 05 Mar 2026 2025 FY
2023 2,140,951 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.